CVS Health Future Growth

Future criteria checks 1/6

CVS Health is forecast to grow earnings and revenue by 6.6% and 5% per annum respectively. EPS is expected to grow by 8.6% per annum. Return on equity is forecast to be 13.4% in 3 years.

Key information

6.6%

Earnings growth rate

8.6%

EPS growth rate

Healthcare earnings growth12.3%
Revenue growth rate5.0%
Future return on equity13.4%
Analyst coverage

Good

Last updated20 Mar 2024

Recent future growth updates

Recent updates

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

CVS Health: Not One Dividend Cut In 30 Years And A Good Upside

Nov 27

CVS Health: All Eyes On December Investor Day

Nov 21

CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work

Oct 26

CVS Health: 'Only' A Fair Company For A Wonderful Price?

Oct 20

CVS Health Offers Recession-Resistant Growth With Transformation

Oct 05

CVS Stock: The Risk-Reward Is In A Better Place

Sep 18

CVS Health: Share Price Suffers As Business Transformation Flounders

Aug 25

Is CVS Health (NYSE:CVS) A Risky Investment?

Aug 25
Is CVS Health (NYSE:CVS) A Risky Investment?

Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation

Aug 16

CVS Health: Second Quarter Was Only Decent, But Integration Is On Track

Aug 03

Earnings and Revenue Growth Forecasts

NYSE:CVS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026415,75710,47112,27915,37213
12/31/2025392,0279,86411,30014,26224
12/31/2024370,8118,8079,19712,27822
12/31/2023356,6238,34410,39513,426N/A
9/30/2023346,6018,47011,30214,110N/A
6/30/2023338,0722,80317,67420,517N/A
3/31/2023329,9153,93117,39220,052N/A
12/31/2022321,6294,31113,45016,177N/A
9/30/2022314,3433,28319,49822,134N/A
6/30/2022306,9338,28715,86818,532N/A
3/31/2022298,7708,04116,19418,936N/A
12/31/2021290,9128,00115,74518,265N/A
9/30/2021283,9817,58615,19117,827N/A
6/30/2021277,2857,21211,61814,180N/A
3/31/2021270,1157,40412,92815,452N/A
12/31/2020267,9087,18813,42815,865N/A
9/30/2020265,2857,95112,64114,932N/A
6/30/2020262,9808,25713,62815,986N/A
3/31/2020260,9617,21711,72214,205N/A
12/31/2019255,7656,62910,39112,848N/A
9/30/2019243,3314,46410,21812,693N/A
6/30/2019226,0534,3248,44810,862N/A
3/31/2019209,623-1746,1878,458N/A
12/31/2018193,919-5976,8288,865N/A
9/30/2018188,0553,0984,2926,250N/A
6/30/2018186,9672,9895,8227,764N/A
3/31/2018185,9446,6454,8866,829N/A
12/31/2017184,7656,6066,0898,007N/A
9/30/2017182,3515,029N/A10,264N/A
6/30/2017180,7855,281N/A11,587N/A
3/31/2017178,8255,108N/A11,235N/A
12/31/2016177,5265,291N/A10,141N/A
9/30/2016172,7015,084N/A11,591N/A
6/30/2016166,7294,781N/A9,477N/A
3/31/2016160,1735,126N/A8,867N/A
12/31/2015153,2905,202N/A8,539N/A
9/30/2015149,1995,027N/A8,264N/A
6/30/2015145,5774,741N/A8,089N/A
3/31/2015143,0104,713N/A7,949N/A
12/31/2014139,3674,626N/A8,137N/A
9/30/2014135,1424,576N/A6,252N/A
6/30/2014132,0534,887N/A6,310N/A
3/31/2014128,6994,775N/A6,315N/A
12/31/2013126,7614,600N/A5,783N/A
9/30/2013125,3124,450N/A5,976N/A
6/30/2013123,6074,206N/A5,196N/A
3/31/2013123,0734,048N/A5,525N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CVS's forecast earnings growth (6.6% per year) is above the savings rate (2.3%).

Earnings vs Market: CVS's earnings (6.6% per year) are forecast to grow slower than the US market (13.5% per year).

High Growth Earnings: CVS's earnings are forecast to grow, but not significantly.

Revenue vs Market: CVS's revenue (5% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: CVS's revenue (5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CVS's Return on Equity is forecast to be low in 3 years time (13.4%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.